Posts filtered by tags: Ugur Sahin[x]


 

The COVID vaccine was developed in record time thanks to mRNA. Pfizer's CEO says the technology should now be used on other viral diseases like the flu.

The Pfizer Covid-19 vaccine. Dado Ruvic/Reuters Dado Ruvic/Reuters Covid-19 vaccine forwarded vaccine science years, Pfizer's CEO said, and now it's time to use advances for other viral diseases, such as the flu. "We'll be able to provide medical solutions for other devastating diseases," the CEO said. The Pfizer BioNTech vaccine used a new method with messenger RNA to initiate the immune response. Moderna's vaccine also used mRNA. Visit Business Insider's homepage for more stories. The Co...
Tags: News, Trends, Healthcare, Fda, Pfizer, Vaccine, Flu Vaccine, Jpmorgan, Moderna, mRNA, Albert Bourla, Bourla, Burla, Ugur Sahin, Natasha Dailey, Reuters Dado Ruvic Reuters Covid


What to say to a friend who's skeptical of getting the coronavirus vaccine

Ohio State employee Lauren Chisholm, left, receives a Pfizer-BioNTech COVID-19 vaccination from Robert Weber AP Photo/Jay LaPrete The FDA has authorized two coronavirus vaccines for emergency use. Neither vaccine raised any major safety concerns in large clinical trials among diverse groups of volunteers. Here are nine reasons to be confident in the safety of these vaccines. Visit Business Insider's homepage for more stories. Around 5.3 million initial doses of the coronavirus vaccine have...
Tags: Hong Kong, Science, News, Cdc, Senate, US, Toronto, Trends, Features, Atlantic, Washington Dc, New York Times, National Institutes of Health, Columbia University, Philadelphia, Fda


BioNTech founders warn of vaccine shortfall

The company’s CEO Uğur Şahin said his company is in talks with Pfizer to boost production.
Tags: Pfizer, Ugur Sahin


AstraZeneca's vaccine is expected to work on new COVID-19 strains, says CEO

AstraZeneca's COVID-19 vaccine. Dado Ruvic/Reuters AstraZeneca CEO Pascal Soriot says his company's COVID-19 vaccine "should remain effective" against mutated virus strains, reports The Sunday Times.  "But we can't be sure, so we're going to test that," Soriot told the newspaper. A new virus strain discovered in the UK may be up to 70% more transmissible, according to Reuters. At least 7 people in Japan tested positive for the new variant, reports The Associated Press.  Visit Business ...
Tags: Japan, UK, Science, London, News, Trends, South Africa, NHS, Astrazeneca, Associated Press, Pfizer, Vaccine, University of Oxford, Pascal Soriot, Oxford University, Reuters


BioNTech's CEO said there's a 'relatively high' possibility the vaccine they made with Pfizer will protect against the UK's new coronavirus variant

An Ohio State employee receives a Pfizer-BioNTech COVID-19 vaccination. AP Photo/Jay LaPrete BioNTech CEO Ugur Sahin, whose company is Pfizer's vaccine partner in Europe, told reporters on Tuesday that the "likelihood" their shot would work with regards to the UK variant was "relatively high," the Associated Press reported. Sahin noted that "we don't know at the moment if our vaccine is also able to provide protection against this new variant," and it will take up to two weeks to get da...
Tags: Europe, UK, England, Science, News, Israel, US, Trends, Ap, Healthcare, Food And Drug Administration, Fda, Associated Press, University of Bristol, Pfizer, Vaccine


BioNTech vaccine 'highly likely' to work against new Covid variant, says chief executive – video

The chief executive of the German pharmaceutical company BioNTech said he was confident its coronavirus vaccine worked against the new UK variant, but that further studies were needed to be certain. 'Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variants,' Uğur Şahin said. If the vaccine needs to be adjusted for the new variant, the company could do that in about six weeks, he addedCovid vaccine 'highly likely' to work on UK variant...
Tags: Europe, UK, Germany, Pharmaceuticals industry, BioNtech, Coronavirus, Ugur Sahin


Covid vaccine 'highly likely' to work on UK variant, BioNTech says

Chief executive, Uğur Şahin, says team will know within two weeks if vaccine works or needs adaptionCoronavirus – latest updatesSee all our coronavirus coverageThe chief executive of the German pharmaceutical company BioNTech has said he is confident its coronavirus vaccine works against the new UK variant, but that further studies are need to be certain.Uğur Şahin told a press conference that his team had been working on trying to find out whether the vaccine worked on the UK variant or whether...
Tags: Europe, UK, Germany, UK News, Pharmaceuticals industry, BioNtech, Coronavirus, Ugur Sahin


Meet the married billionaire couple who helped create the BioNTech/Pfizer vaccine

Dr. Ugur Sahin and Dr. Özlem Türeci. Stefan F. So¤mmer via www.imago-images.de/Reuters The German couple behind BioNTech is one of the driving forces behind Pfizer's historic coronavirus vaccine, which has now been authorized in the UK and US, and is recommended for use in the EU Dr. Ugur Sahin is the CEO and Dr. Özlem Türeci the chief medical officer of BioNTech, the company that created the vaccine in partnership with Pfizer. The couple crossed the billionaire threshold in June, when Bi...
Tags: UK, Germany, US, Trends, Eu, Bloomberg, Turkey, Cologne, New York Times, Tokyo, Pfizer, Times, Istanbul, Wuhan, Cdu, Forbes


9 things to say to a friend who's skeptical of getting the coronavirus vaccine

Ohio State employee Lauren Chisholm, left, receives a Pfizer-BioNTech COVID-19 vaccination from Robert Weber AP Photo/Jay LaPrete The FDA authorized the coronavirus vaccine from Pfizer and BioNTech for emergency use on Friday. Moderna's coronavirus vaccine is likely to be next. Neither vaccine raised any major safety concerns in large clinical trials among diverse groups of volunteers. Here are nine reasons to be confident in the safety of these vaccines. Visit Business Insider's homepage ...
Tags: Hong Kong, Science, News, Cdc, Senate, US, Toronto, Trends, Features, Atlantic, Washington Dc, New York Times, Food And Drug Administration, Columbia University, Philadelphia, Fda


A comprehensive timeline of the coronavirus pandemic at 1 year, from China's first case to the present

Medical staff wearing protective gear move a patient infected with the coronavirus from an ambulance to a hospital on March 9, 2020 in Seoul, South Korea. Chung Sung-Jun/Getty Images The 1-year anniversary of the coronavirus pandemic has arrived: The first case was confirmed in Wuhan, China, in December 2019. Chinese government data suggests the virus was likely circulating by mid-November. In the year since, the virus has infected more than 73 million people and killed more than 1...
Tags: Health, South Korea, Europe, UK, Science, London, News, Supreme Court, Congress, California, Cdc, Washington, France, Senate, White House, China


The coronavirus vaccine rollout has begun

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hollis Johnson/Business Insider Hello,What a weekend! As you likely know by this point, on Friday the Food and Drug Administration granted an emergency use authorization for Pfizer and BioNTech's coronavirus vaccine. The vaccine left Pfizer's Michigan facility on Sunday and shipped out across the country. Si...
Tags: London, Cdc, US, Trends, Healthcare, Food And Drug Administration, Michigan, Fda, Belfast, Pfizer, Vaccine, Houston, Wall Street Journal, Sanofi, Sahin, Liam McBurney


The co-founder of BioNTech designed the coronavirus vaccine it made with Pfizer in just a few hours over a single day

Dr. Ugur Sahin and Dr. Özlem Türeci, co-founders of BioNTech. Stefan F. So¤mmer via www.imago-images.de/Reuters The FDA granted emergency authorization to Pfizer and BioNTech's coronavirus vaccine on Friday evening. The vaccine, which was found to be 95% effective in trials, was designed by BioNTech co-founder Ugur Sahin in one day: January 25.   In fact, according to The Wall Street Journal's podcast, Sahin designed the vaccine in just a few hours. Visit Business Insider's homepage for m...
Tags: Health, Science, News, China, US, Trends, Atlantic, South Africa, Healthcare, Food And Drug Administration, Fda, Pfizer, Anthony Fauci, Wall Street Journal, Wuhan, Journal


US Covid-19 vaccine authorization is 'a most important milestone,' BioNTech CEO says

The US Food and Drug Administration's emergency use authorization of Pfizer and BioNTech's coronavirus vaccine is a crucial step in developing the new-generation vaccine, BioNTech CEO Ugur Sahin says.
Tags: US, Cnn, Pfizer, US Food and Drug Administration, Ugur Sahin


The FDA is preparing to authorize Pfizer's vaccine

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hollis Johnson/Business Insider Hello,What a week it's been. If you had any doubts this month could be one long marathon of vaccine news, this week certainly proved the case.In the last week alone, we saw the peer-review publication of data on both AstraZeneca/Oxford and Pfizer/BioNTech's shots.We got detail...
Tags: UK, US, West Virginia, Trends, Bloomberg, Walgreens, Chicago, Healthcare, M&a, Fda, Belfast, Pfizer, Vaccine, Polaroid, Kleiner Perkins, Forbes


A comprehensive timeline of the coronavirus pandemic at 12 months, from China's first case to the present

Medical staff wearing protective gear move a patient infected with the coronavirus from an ambulance to a hospital on March 9, 2020 in Seoul, South Korea. Chung Sung-Jun/Getty Images The 1-year anniversary of the coronavirus pandemic has arrived: The first case was confirmed in Wuhan, China, in December 2019. Chinese government data suggests the virus was likely circulating by mid-November. In the year since, the virus has infected more than 64 million people and killed nearly 1.5 ...
Tags: Health, South Korea, Europe, UK, Science, London, News, Congress, California, Cdc, Washington, France, Senate, White House, China, Russia


Celebrating the Path-Breaking Research That Lead to Coronavirus Vaccines

The Washington Post tells the remarkable story of how both Moderna's vaccine and the Pfizer/BioNTech vaccine relied on a specially designed spike protein partially created by America's Vaccine Research Center — along with messenger RNA, "a technology never before harnessed in an approved vaccine." And also decades of path-breaking research: If, as expected in the next few weeks, regulators give those vaccines the green light, the technology and the precision approach to vaccine design could tu...
Tags: Post, Washington Post, America, Tech, United States, Anthony Fauci, Sahin, Wuhan China, Melissa Moore, Moderna, Vaccine Research Center, BioNtech, Ugur Sahin, Barney -RSB- Graham, Moderna RNA


The UK approves the BioNTech/Pfizer COVID-19 vaccine for emergency use

The UK government has approved the BioNTech/Pfizer vaccine against COVID-19 for emergency use, following the recommendation of the national medicines regulator. The UK is the first country to approve the vaccine for widespread use — paving the way for some of the most “high risk” citizens, such as elderly care home residents and front-line healthcare workers, to get the jab before the end of the year. The BBC reports that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has sa...
Tags: Health, Europe, UK, Tech, Bbc, NHS, National Health Service, Simon Stevens, Boris Johnson, Pfizer, Vaccine, Hancock, Matt Hancock, MHRA, BioNtech, Albert Bourla


How a Couple’s Quest to Cure Cancer Led to the West’s First Covid-19 Vaccine

The founders of BioNTech, the husband-wife team of Ugur Sahin and Özlem Türeci, are behind the company’s successful launch of the first...
Tags: Ugur Sahin


The vaccine breakthroughs at Moderna and Pfizer are the latest examples of how immigrants have been driving billions in American innovation for decades

Noubar Afeyan, an immigrant from Lebanon, is the co-founder and chairman of Moderna, the company behind one of the most promising potential COVID019 vaccines. Flagship Pioneering Behind both Moderna and the Pfizer-BioNTech potential coronavirus vaccines are a group of incredible scientists, biotech CEOs, and venture capitalists funding the effort — many of whom are immigrants. Business Insider spoke with Moderna cofounder and chairman Noubar Afeyan, an immigrant himself, abou...
Tags: Spacex, Elon Musk, Greece, France, Germany, Russia, US, America, Trends, Tesla, Bloomberg, Turkey, Joe Biden, Mit, Cologne, Canada


2 stocks to buy on the Amazon Pharmacy news

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hollis Johnson/Business Insider Hello,Today in healthcare news: why Wall Street analyst thinks two of the healthcare stocks pummeled by the news of Amazon Pharmacy will explode, BI Deutschland's interview with BioNTech's CEO, and Moderna salaries revealed.   Customers can now purchase prescription medica...
Tags: Amazon, Wall Street, US, Trends, Healthcare, Pfizer, Vaccine, New Mexico, Pharmacy, Don, AmerisourceBergen, Moderna, BioNtech, Business Insider New York, BLAKE DODGE, GoodRx


BioNTech and Pfizer will seek emergency US authorization for vaccine on Friday, CEO says

German company BioNTech and its partner, drug giant Pfizer, will ask the US on Friday to allow emergency use of their Covid-19 vaccine candidate, CEO Ugur Sahin told CNN during an exclusive interview on Wednesday.
Tags: US, Cnn, Pfizer, BioNtech, Ugur Sahin


A scientist who helped make the Pfizer vaccine predicted life being back to normal within a year if enough people take it

Ugur Sahin, the CEO of BioNTech, in November 2019. Andreas Arnold/picture alliance via Getty Images The head of the company that helped created Pfizer's effective coronavirus said life could be "normal" within a year if enough people are vaccinated. Professor Ugur Sahin, the chief executive of German company BioNTech, told the BBC that high vaccine update may mean "we could have a normal winter next year." He said the number of vaccines under development means he is "confident" that hurdle...
Tags: Science, US, Trends, Bbc, News UK, Andrew Marr, Pfizer, Anthony Fauci, Sahin, Cincinnati Children, Moderna, BioNtech, Coronavirus, COVID-19, Coronavirus Vaccine, Covid-19 Vaccine


The creator of the Pfizer-BioNTech vaccine says life could return to normal by next winter

Professor Ugur Sahin, co-founder and chief executive of BioNTech, also suggested the coronavirus vaccine could halve transmission of the virus.
Tags: BioNtech, Ugur Sahin


Global stocks rise on further dose of COVID-19 vaccine positivity and strong China factory data

Reuters / Brendan McDermid Global stocks jumped on Monday, boosted by a newly positive COVID-19 vaccine backdrop and stronger industrial data from China.  Investors are eagerly anticipating results from vaccine candidates including Moderna, AstraZeneca, and Janssen."The road to full economic reopening is slow, but the 'long vaccine' trade remains live," Axi's chief market strategist said.President Donald Trump plans to introduce fresh sanctions against China and promote hawkish government ...
Tags: Hong Kong, Japan, UK, China, Germany, Global, US, Trends, Opec, Joe Biden, Britain, Astrazeneca, Pfizer, Oxford University, Madrid, Donald Trump


Coronavirus vaccine scientist: ‘We could have a normal winter next year’

BioNTech co-founder Uğur Şahin says he didn’t get any help from US Operation Warp Speed, as claimed by Donald Trump.
Tags: Ugur Sahin, US Operation Warp Speed


Covid-19 vaccine: 'We could have a normal winter next year'

BioNTech CEO Ugur Sahin tells Andrew Marr about his company's promising coronavirus vaccine trials.
Tags: Health, Andrew Marr, Ugur Sahin


The modern-day Curies: Meet the scientist couple behind 90% effective COVID-19 vaccine

Ozlem Tureci and Ugur Sahin are rapidly becoming the most celebrated marriage in science since Marie and Pierre Curie discovered radioactivity.
Tags: Marie, Pierre Curie, Ugur Sahin, Özlem Türeci


A billionaire couple is behind the historic coronavirus vaccine

Dr. Ugur Sahin and Dr. Özlem Türeci. Stefan F. So¤mmer via www.imago-images.de/Reuters A scientist power-couple is a driving force behind Pfizer's new coronavirus vaccine. Dr. Ugur Sahin is the CEO and Dr. Özlem Türeci the chief medical officer of BioNTech, the company that created the vaccine in partnership with Pfizer. Business Insider took a deep dive into who they are, and how they've made their mark on modern medicine. Visit Business Insider's homepage for more stories. Pfizer's new ...
Tags: Germany, Trends, Pfizer, Sahin, BioNtech, Juliana Kaplan, Ugur Sahin, Özlem Türeci, Türeci, Pfizer Business Insider


Their coronavirus vaccine candidate has made them billionaires. This modest German Turkish couple doesn’t own a car

Ugur Sahin and Ozlem Tureci, founders of BioNTech, are working with Pfizer.
Tags: Ugur Sahin, Özlem Türeci


Scientist behind BioNTech/Pfizer vaccine says it can end pandemic

Exclusive: BioNTech’s CEO Uğur Şahin says he is confident vaccine can ‘bash the virus over the head’Coronavirus – latest updatesSee all our coronavirus coverageThe scientist behind the first vaccine against Covid-19 to clear interim clinical trials says he is confident that his product can “bash the virus over the head” and put an end to the pandemic that has held the world hostage in 2020.German company BioNTech and US pharmaceutical giant Pfizer announced via a press release on Monday that the...
Tags: Health, Science, Germany, US, Society, World news, Pharmaceuticals industry, Vaccines and immunisation, Pfizer, Donald Trump, BioNtech, Coronavirus, COVID, Ugur Sahin, BioNTech Pfizer